Discover 661 paid clinical trials in Sheboygan, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 661
Impella RP Flex with Smart Assist
for
Right Ventricular (RV) Dysfunction
Location: Milwaukee WI, Detroit MI, Coon Rapids MN, Cincinnati OH,
Sponsor: Abiomed Inc.
Sex: All
Age: 0+
Code: NCT06637644
Recruiting
Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses
for
Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT05674825
Phase1, Phase2, Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for
Superficial Bladder Cancer,
Location: Milwaukee WI, Grand Rapids MI, Rochester MN, Detroit MI,
Sponsor: enGene, Inc.
Sex: All
Age: 18+
Code: NCT04752722
Phase1, Phase2, Recruiting
Pulmonary Hypertension Association Registry
for
Pulmonary Arterial Hypertension,
Location: Milwaukee WI, Madison WI, Rochester MN, Iowa City IA,
Sponsor: Pulmonary Hypertension Association, Inc.
Sex: All
Age: 0+
Code: NCT04071327
Recruiting
Cardiac Arrest Recovery EEG Study
for
Cardiac Arrest, Arrhythmia
Location: Milwaukee WI, Baltimore MD
Sponsor: Infinite Biomedical Technologies
Sex: All
Age: 18+
Code: NCT00483873
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
for
Diffuse Large B Cell Lymphoma (DLBCL)
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 70+
Code: NCT06594939
Phase2, Recruiting
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
for
Multiple Myeloma
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18 - 70+
Code: NCT05976555
Phase1, Recruiting
Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
for
Psoriatic Arthritis (PsA)
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT07111494
Recruiting
US Zamto-cel Autoimmune Diseases
for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: Milwaukee WI
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT06708845
Phase1, Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
for
Hodgkin Disease, CD30-Positive Diffuse Large B-Cell Lymphoma,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT05544968
Phase1, Recruiting
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
for
Advanced Renal Cell Carcinoma (aRCC),
Location: Milwaukee WI, Nashville TN, Hershey PA,
Sponsor: Brian Rini
Sex: All
Age: 18+
Code: NCT07188896
Phase2, Recruiting
Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
for
Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer,
Location: Milwaukee WI, Atlanta GA, Lebanon NH, Honolulu HI
Sponsor: OncoTherapy Science, Inc.
Sex: All
Age: 18+
Code: NCT02926690
Phase1, Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: Milwaukee WI, Rochester MN, Maumee OH, Indianapolis IN,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07252232
Phase3, Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for
Acute Myeloid Leukemia (AML)
Location: Milwaukee WI, Madison WI, Ann Arbor MI, Iowa City IA,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07007312
Phase3, Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue